(Q51710529)

10 April 2018

editorial

0 references

title

Granulocyte macrophage-colony stimulating factor augmentation therapy in sepsis: is there a role? (English)

1 reference

10 April 2018

1 reference

1 reference

Bruce C Trapnell

1

1 reference

10 April 2018

language of work or name

English

0 references

publication date

1 July 2002

1 reference

10 April 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

10 April 2018

volume

166

1 reference

10 April 2018

issue

2

1 reference

10 April 2018

page(s)

129-130

1 reference

10 April 2018

The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2205017

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2205017

Pathogenetic mechanisms of septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2205017

Dysregulation of in vitro cytokine production by monocytes during sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2205017

Gm-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2205017

A randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2205017

A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2205017

Treating patients with severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2205017

Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2205017

Granulocyte-macrophage colony-stimulating factor induces activation and restores respiratory burst activity in monocytes from septic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2205017

Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2205017

21 January 2018

Identifiers

DOI

10.1164/RCCM.2205017

1 reference

10 April 2018

1 reference

10 April 2018